May 2018

Feature

From the Field

A Novel Clinical Pathways Approach to Delivering Regional-Based Clinical Trials and Patient Care in a Hybrid Academic-Community-Based System

05/15/2018

Kathryn E Patronik, MHA

Edward S Kim, MD, FACP

Abstract: The health care landscape is becoming constantly more complex with new drug treatments and molecular testing. In order to achieve consistent, up-to-date patient care, clinical pathways are becoming...

...

05/15/2018

Journal of Clinical Pathways

From the Field

A Community Practice Perspective on Implementation of the Oncology Care Model

05/15/2018

Anne Marie Fraley Rainey, MSN, RN, CHC

Abstract: Clearview Cancer Institute is a private, community practice participating in the Oncology Care Model (OCM), an innovative pilot project sponsored by the Centers for Medicare and Medicaid Innovation....

...

05/15/2018

Journal of Clinical Pathways

Column

PATIENT PERSPECTIVE

Granularity: The Missing Link in Clinical Pathways

05/15/2018

Alan J Balch, PhD—Column Editor

Christine M Wilson, MS

Most clinical pathways have not been designed to incorporate the full spectrum of the patient experience, which includes elements not immediately related to clinical considerations. Changing that requires a...

Most...

05/15/2018

Journal of Clinical Pathways

Pharma Insights

Factors Influencing the Implementation of Value-Based Contracting Between Pharmaceutical Manufacturers and Payers

05/15/2018

Marylou Buyse, MD

Stephen Carter, BSc

Kyle Sarnataro, BSc

Value-based payments between payers and providers are growing steadily. Yet, despite apparently high interest, value-based contracting between payers and manufacturers appears to be growing slowly and more unevenly....

...

05/15/2018

Journal of Clinical Pathways

Clinical Pathways GPS

Emerging Care Delivery Models Where Payers and Providers Become One

05/15/2018

Richard G Stefanacci, DO, MGH, MBA, AGSF, CMD—Column Editor

The trend of reducing health care costs through global capitation and aggressive contracting from payer/provider integration has and will continue to expand in the health care market. This combination will provide a...

The...

05/15/2018

Journal of Clinical Pathways

Editor's Page

Early Learnings From Innovators in the Pursuit of Value-Based Care

05/15/2018

Winston Wong, PharmD, Editor-in-Chief

Making the transition from fee-for-service reimbursement to value-based models of care and payments will be slow and difficult. As the initial concepts behind value-based reimbursement and care delivery models...

Making...

05/15/2018

Journal of Clinical Pathways

Department

Pathways in Practice

Clinical Pathway Development for Early-Stage and Metastatic HER2-Positive Breast Cancer

05/15/2018

JCP Editors

In this new series, we speak with cancer care practitioners about pathways being used in their practices, how they are being applied in a particular disease state, and what challenges persist for treatment...

In...

05/15/2018

Journal of Clinical Pathways

Community Oncology Alliance Annual Conference

05/15/2018

JCP Editors

The Community Oncology Alliance (COA) is the only organization focused on oncology care delivery in the community setting, the setting where most Americans with cancer are treated. COA aims to ensure that patients...

The...

05/15/2018

Journal of Clinical Pathways

Current Issue

June 2024

Volume 10

Issue 3

Current Issue

Issue Archive

Special Reports

Sponsored

Special Report

Shedding Light on Non-Small Cell Lung Cancer & Its Impact on Patients

04/03/2023

This supplement aims to raise awareness about non-small cell lung cancer (NSCLC) and its impact on patients by providing comprehensive information to help improve early detection and appropriate care.

This supplement aims to raise...

04/03/2023

Journal of Clinical Pathways

Sponsored

JCP Special Report

Brukinsa® (Zanubrutinib) for Chronic Lymphocytic Leukemia

03/31/2023

In this product monograph, read an interview with Jeff P. Sharman, MD, as he discusses important BRUKINSA® trial data including efficacy, safety, dosing, administration, and other relevant data. These key findings supported the Food and Drug...

In this product monograph, read...

03/31/2023

Journal of Clinical Pathways

Sponsored

JCP Special Report

Tumor Lysis Syndrome: Early Diagnosis and Management

01/04/2023

This review summarizes the diagnosis, pathophysiology, and evidence-based guidelines for the prevention and management of tumor lysis syndrome, a common, acute, life-threatening disease primarily in patients with hematologic cancers and solid...

This review summarizes the...

01/04/2023

Journal of Clinical Pathways

Sponsored

JCP Special Report

A Tumor Lysis Syndrome Risk Assessment and Its Impact on Patients

08/09/2022

In an interview with Journal of Clinical Pathways, Nicholas Short, MD, shares objectives on the design and benefits of MD Anderson’s Tumor Lysis Syndrome clinical assessment for patient risk and impact on patient care.

In an interview with Journal of...

08/09/2022

Journal of Clinical Pathways

Updated NCCN Guidelines on B-Cell Lymphomas

Sponsored

JCP Special Report

Overview of the Updated NCCN Guidelines on B-Cell Lymphomas

06/15/2022

Robert Fee

Updated multiple times in 2022, the National Comprehensive Cancer Network (NCCN) Guidelines for B-Cell Lymphomas provide recommendations for the prevention, diagnosis, and management of malignancies.

Updated multiple times in 2022,...

06/15/2022

Journal of Clinical Pathways

Sponsored

Special Report

Expanded Indication for Zanubrutinib: Marginal Zone Lymphoma and Waldenström’s Macroglobulinemia

06/10/2022

In an interview with Journal of Clinical Pathways, Mitul Gandhi, MD, reviews the clinical impact and treatment approaches and challenges for patients with marginal zone lymphoma and Waldenström’s macroglobulinemia.

In an interview with Journal of...

06/10/2022

Journal of Clinical Pathways

JCP Special Report

Recommendations for Creating an Oncology Clinical Pathways Framework Tool Based on Payer, Provider, and Patient Priorities: Findings From the 2021 Care Pathways Working Group

05/20/2022

Winston Wong, PharmD

Gordon Kuntz

Robin T Zon, MD, FACP, FASCO

2021 Care Pathways Working Group

The Journal of Clinical Pathways convened the 2021 Care Pathways Working Group to identify and reconcile the different pathway drivers for each stakeholder now and five years into the future, creating a framework tool based on oncology care...

The Journal of Clinical Pathways...

05/20/2022

Journal of Clinical Pathways

Overview of the Updated NCCN Guidelines on Triple-Negative Breast Cancer

Sponsored

Special Report

Overview of the Updated NCCN Guidelines on Triple-Negative Breast Cancer

12/15/2021

Deborah Abrams Kaplan

NCCN released updates to its practice guidelines on treating triple-negative breast cancer, featuring updates on sacituzumab govitecan recommendations and more.

NCCN released updates to its...

12/15/2021

Journal of Clinical Pathways

Sponsored

Special Report

Navigating the Patient Journey for Unresectable Stage III Non-Small Cell Lung Cancer

09/16/2021

.ryan-test { display: none; } .body-content h3 { font-size: 18px; line-height: 18px; color: #000000; font-weight: 600px; } .related-content { display: none; } .body-content div > div:nth-of-type(3) .paragraph > h3 >...

.ryan-test { display:...

09/16/2021

Journal of Clinical Pathways

$Clinical Pathways Updates in Multiple Myeloma: New and Expected Treatments for Refractory and Resistant Multiple Myeloma$

Special Report

Clinical Pathways Updates in Multiple Myeloma: New and Expected Treatments for Refractory and Resistant Multiple Myeloma

01/14/2021

Journal of Clinical Pathways

Journal of Clinical Pathways Newsletter

Editorial Correspondence

May 2018

Feature

Column

Department

Current Issue

Special Reports

Subscribe

Volume 4

Specialties

Events

Year Round Education

HMP Global Products